Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women at least 12 months since last menses.Prevention of osteoporosis in postmenopausal women at high risk of future fractures. Femoston contini 1/5 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.Femoston is indicated for women with an intact uterus